A novel strategy for PLK1 kinase inhibition by allosterically targeting the Polo Box Domain.

被引:0
|
作者
Chapagai, Danda [1 ]
Baxter, Merissa [2 ]
Craig, Sandra [3 ]
Ramamoorthy, Guru [1 ]
Stafford, Jessy [1 ]
Vitali, Sikirzhytski [1 ]
Nurmemmedov, Elmar [4 ]
McInnes, Campbell [1 ]
Wyatt, Michael D. [1 ]
机构
[1] Univ South Carolina, Columbia, SC USA
[2] NCI Shady Grove, Rockville, MD USA
[3] Coll Charleston, Charleston, SC USA
[4] Providence St Johns Hlth Ctr, Santa Monica, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2572
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Deficiency in Chromosome Congression by the Inhibition of Plk1 Polo Box Domain-dependent Recognition
    Watanabe, Nobumoto
    Sekine, Tomomi
    Takagi, Masatoshi
    Iwasaki, Jun-ichi
    Imamoto, Naoko
    Kawasaki, Hisashi
    Osada, Hiroyuki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (04) : 2344 - 2353
  • [2] Identification of a nuclear localization signal in the polo box domain of Plk1
    Lee, Moon-Sing
    Huang, Yi-Han
    Huang, Shu-Ping
    Lin, Ru-Inn
    Wu, Shu-Fen
    Li, Chin
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (10): : 1571 - 1578
  • [3] Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain
    Shin, Sol-Bi
    Woo, Sang-Uk
    Yim, Hyungshin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2015, 230 (12) : 3057 - 3067
  • [4] Different Plk1 functions show distinct dependencies on polo-box domain-mediated targeting
    Hanisch, A
    Wehner, A
    Nigg, EA
    Silljé, HHW
    MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (01) : 448 - 459
  • [5] Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their Prodrugs
    Park, Jung-Eun
    Lee, Hobin
    Oliva, Paola
    Kirsch, Klara
    Kim, Bora
    Ahn, Jong Il
    Alverez, Celeste N.
    Gaikwad, Snehal
    Krausz, Kristopher W.
    O'Connor, Robert
    Rai, Ganesha
    Simeonov, Anton
    Mock, Beverly A.
    Gonzalez, Frank J.
    Lee, Kyung S.
    Jacobson, Kenneth A.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2023, 6 (03) : 422 - 446
  • [6] Computational assessment of potential nonpeptidic inhibitors for PLK1 polo-box domain
    Kucukkal, Tugba G.
    Lawal, Monsurat
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 470A - 470A
  • [7] Inhibition of polo kinase 1 (Plk1) affects resumption of meiosis in porcine oocytes
    Kalous, J.
    Motlik, J.
    REPRODUCTION IN DOMESTIC ANIMALS, 2010, 45 : 92 - 92
  • [8] Structure-based development of biovailable polo-like kinase 1 (Plk1) polo-box domain-binding peptides
    Qian, Wenjian
    Park, Jung-Eun
    Liu, Fa
    Lim, Dan
    Scharow, Andrej
    Berg, Thorsten
    Yaffe, Michael B.
    Lee, Kyung S.
    Burke, Terrence R., Jr.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [9] TARGETING POLO-LIKE KINASE 1 (PLK1) FOR TREATMENT OF PEDIATRIC BRAIN CANCERS
    Lee, Cathy Y.
    Fotovati, Abbas
    Dunn, Sandra E.
    NEURO-ONCOLOGY, 2010, 12 : 11 - 11
  • [10] Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1
    Ryu, SeongShick
    Park, Jung-Eun
    Ham, Young Jin
    Lim, Daniel C.
    Kwiatkowski, Nicholas P.
    Kim, Do-Hee
    Bhunia, Debabrata
    Kim, Nam Doo
    Yaffe, Michael B.
    Son, Woolim
    Kim, Namkyoung
    Choi, Tae-Ik
    Swain, Puspanjali
    Kim, Cheol-Hee
    Lee, Jin-Young
    Gray, Nathanael S.
    Lee, Kyung S.
    Sim, Taebo
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (03) : 1915 - 1932